CS logo
small CS logo
iBiomed Research Unit

Aguascalientes, Mexico
Corporate office
,20127, Sierra Fría 218, Bosques del Prado Nte., Aguascalientes, Ags.

About iBiomed Research Unit


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at iBiomed Research Unit


During the past decade, iBiomed Research Unit conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110011001144000000000000Started TrialsCompleted Trails2017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
2017-11-07
2025-12-22
Active, not recruiting
390
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
2019-01-25
2027-02-19
Active, not recruiting
765
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
2021-07-15
2026-04-17
Recruiting
190
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
2022-01-31
2025-04-25
Recruiting
320
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
2022-03-07
2025-08-18
Recruiting
516
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
2022-07-25
2027-02-01
Recruiting
440
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer
2022-07-20
2027-05-01
Recruiting
540

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "iBiomed Research Unit" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at iBiomed Research Unit


According to Clinical.Site data, the most researched conditions in "iBiomed Research Unit" are "Triple Negative Breast Cancer" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Gastric Cancer" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Myasthenia Gravis" (1 trials). Many other conditions were trialed in "iBiomed Research Unit" in a lesser frequency.

Clinical Trials Intervention Types at iBiomed Research Unit


Most popular intervention types in "iBiomed Research Unit" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials) and "Sacituzumab Govitecan-hziy" (2 trials). Other intervention names were less common.

Clinical Trials Genders at iBiomed Research Unit


The vast majority of trials in "iBiomed Research Unit" are 6 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at iBiomed Research Unit


Currently, there are NaN active trials in "iBiomed Research Unit". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in iBiomed Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in iBiomed Research Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status